JACKSONVILLE, FL | September 19, 2023
The American Lung Association is pleased to announce that Jazz Pharmaceuticals has signed on as Presenting Sponsor of the 10th annual LUNG FORCE Run/Walk in Jacksonville. The family-friendly event will take place on Saturday, October 14 along the St. Johns River at Haskell. The festive fundraiser drives the Lung Association’s efforts to improve lung health and prevent lung disease through lifesaving research, education and advocacy.
“We are grateful to Jazz Pharmaceuticals for their crucial support as we commemorate the 10th anniversary of our LUNG FORCE Run/Walk,” said Chris Gonzalez, chair of the Lung Association’s Jacksonville Local Leadership Board of Directors. “We value their partnership and shared vision in a future free of lung cancer and lung disease.”
The LUNG FORCE Run/Walk is a 5K route along the St. Johns River designed for all fitness levels. The event is open to individuals, families and company teams. The vendor village will feature a DJ, a photo booth, food and more.
“We encourage the Jacksonville community to join us to take bold strides to save lives,” Gonzalez added. “Funds raised will support local services, programs and research throughout Florida.”
More than 200,500 people in the Jacksonville area suffer from lung disease, including lung cancer, COPD and asthma. Lung cancer remains the leading cause of cancer deaths in the U.S. In Florida, it is estimated that more than 19,300 people will diagnosed with lung cancer this year, and nearly 10,200 people will die from the disease.
However, there is hope. More Americans than ever are surviving lung cancer. The survival rate has increased by nearly 40 percent in the last decade. Funding research, encouraging lung cancer screening and reducing stigma around the disease is the key to unlocking a future free of lung cancer.
The Jacksonville LUNG FORCE Run/Walk kicks off at 8 a.m., with a 7:30 a.m. registration. For more information and to register, visit LUNGFORCE.org/Jacksonville.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We are a leader in sleep disorders and epilepsy; further developing in movement disorders and PTSD; and focused on hematologic malignancies and solid tumors. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules, biologics, innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. To support the work of the American Lung Association, find a local event at Lung.org/events.
A Breath of Fresh Air in Your Inbox
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
You will now receive email updates from the American Lung Association.